Health News
Granny's Knee Hurts
Do you experience knee pain every day, or just every so often? If you are a woman over the age of 50 and your answer is yes, consider yourself a member of a very large club.
The Right Dose of Speech Therapy
Alzheimer's patients want to feel assured that their medication regimen is protecting them not only from memory loss but from the loss of other functions such as speech. Research finds that medication dosing may be key to preserving language abilities.
Arthritic Children Face Fracture Risk
Juvenile idiopathic arthritis ( JIA ) makes life painful for children and teens. A recent study showed that many JIA patients commonly have spinal fractures and other broken bones.
An Added Punch to Combat Seizures
As some who suffer with it know, epilepsy can be difficult. The fear of seizures can itself be exhausting.
Pfizer Announces New Drug Application For Tofacitinib
Pfizer Inc.announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tofacitinib (development code CP-690 ,550), an investigational novel, oral JAK inhibitor being studied for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).
Saving the Mind From MS
One of the frustrating symptoms of multiple sclerosis (MS) is cognitive decline. Many patients have trouble with concentration, judgment and memory. Researchers wanted to learn if a drug that's effective with early dementia may help MS patients.
Notifications Improve Osteoporosis Care
You've just gotten out of the hospital after a major fracture. You want to avoid the experience again, but are you receiving care to prevent another fracture?
Mirapex Effective for Restless Legs
While restless legs syndrome seems like an odd disorder that some people may find hard to believe, people who suffer the discomfort have no doubt this disorder exists. And now patients have effective treatment choices.
MS Drug Reaffirms Effectiveness in Clinical Trial
Gilenya , a FDA-approved multiple sclerosis drug, had positive results in a late-stage clinical trial. The results may help ease safety concerns about the drug.
Pfizer Reports Positive Results From Lyrica
Pfizer Inc. announced that a Phase 3 study for Lyrica (pregabalin) in patients with restless legs syndrome (RLS) met each of its three co-primary endpoints, showing significant benefit as compared with placebo and pramipexole .